Tactile Systems (TCMD) Technology announced that Nimbl, its next-generation pneumatic compression platform, is now commercially available throughout the United States for the treatment of both upper and lower extremity lymphedema. Nimbl’s expanded availability to include lower extremity conditions follows its commercial introduction in October 2024, initially focused on treating patients suffering from upper extremity lymphedema.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCMD: